Substance Use and Sleep Problems in Patients With Psychotic Disorders

Abstract Background Substance use and sleep problems are common in patients with psychotic disorders, but their associations these have not been evaluated. We aimed to investigate between substance a large nationwide cohort of disorder. Study Design This study is part the Finnish SUPER study, which belongs Stanley Global Neuropsychiatric Genomics Initiative. In this cross-sectional, multicenter participants (N = 8616) were recruited from primary specialized healthcare. Patients schizophrenia, schizoaffective disorder, bipolar depression included. Information on current alcohol (Alcohol Use Disorders Identification Test-Concise) cigarette as well lifetime illicit drug use, including cannabis, benzodiazepines, amphetamines, opioids, was collected using questionnaires. The outcomes our logistic regression analysis short (?6 h) long (?10 duration, difficulties initiating asleep, early morning awakenings, fatigue, poor quality (SQ). Results Self-reported associated higher prevalence problems. After adjustments age, gender, diagnostic group, living status, hazardous (eg, SQ odds ratio [OR] 1.80, 95% CI: 1.49 2.16, P < .001), smoking (short duration OR 1.28, 1.08 1.52, .005), benzodiazepine misuse (difficulties 2.00, 1.55 2.48, .001) Conclusions Our findings underline potential benefits screening when treating disorders.